NCT06299761
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06299761
Title Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications (STARMAP)
Acronym STARMAP
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boundless Bio
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarcoma Oncology Research Center Santa Monica California 90403 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
NEXT Oncology Irving Texas 75039 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field